Rating History for Anavex Life Sciences (AVXL) by Cantor Fitzgerald

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/6/2022 Charles Duncan Downgrade Neutral
(Overweight)
11.00
(16.00)
12.05
(4.65)
-61.41% Details